BibTex RIS Kaynak Göster
Yıl 2016, Cilt: 33 Sayı: 1, 0 - 0, 01.01.2016

Kaynakça

  • 1. Maroun E, Kushawaha A, El-Charabaty E, Mobarakai N, ElSayegh S. Fulminant Leptospirosis (Weil’s disease) in an urban setting as an overlooked cause of multiorgan failure: a case report. J Med Case Rep 2011;5-7.
  • 2. Gancheva G, Karcheva M. Severe leptospirosis observed in a man who had just returned from abroad. Balkan Med J 2013;30:116-9. [CrossRef]
  • 3. Sükran K, Tatar B, Ersan G, Topaloğlu S. A leptospirosis case presenting with thrombotic thrombocytopenic purpura. Balkan Med J 2013;30:436-8. [CrossRef]
  • 4. Chierakul W, Tientadakul P, Suputtamongkol Y, Wuthiekanun V, Phimda K, Limpaiboon R, et al. Activation of the coagulation cascade in patients with leptospirosis. Clin Infect Dis 2008;46:254-60. [CrossRef]
  • 5. Thunga G, John J, Sam KG, Khera K, Khan S, Pandey S, et al. Role of high-dose corticosteroid for the treatment of leptospirosis-induced pulmonary hemorrhage. J Clin Pharmacol 2012;52:114-6. [CrossRef]
  • 6. Minor K, Mohan A. Severe leptospirosis: treatment with intravenous corticosteroids and supportive care. Am J Emerg Med 2013;31:449.e1-2. [CrossRef]

High Efficacy of Prednisolone in a Complicated Case of Weil Disease

Yıl 2016, Cilt: 33 Sayı: 1, 0 - 0, 01.01.2016

Kaynakça

  • 1. Maroun E, Kushawaha A, El-Charabaty E, Mobarakai N, ElSayegh S. Fulminant Leptospirosis (Weil’s disease) in an urban setting as an overlooked cause of multiorgan failure: a case report. J Med Case Rep 2011;5-7.
  • 2. Gancheva G, Karcheva M. Severe leptospirosis observed in a man who had just returned from abroad. Balkan Med J 2013;30:116-9. [CrossRef]
  • 3. Sükran K, Tatar B, Ersan G, Topaloğlu S. A leptospirosis case presenting with thrombotic thrombocytopenic purpura. Balkan Med J 2013;30:436-8. [CrossRef]
  • 4. Chierakul W, Tientadakul P, Suputtamongkol Y, Wuthiekanun V, Phimda K, Limpaiboon R, et al. Activation of the coagulation cascade in patients with leptospirosis. Clin Infect Dis 2008;46:254-60. [CrossRef]
  • 5. Thunga G, John J, Sam KG, Khera K, Khan S, Pandey S, et al. Role of high-dose corticosteroid for the treatment of leptospirosis-induced pulmonary hemorrhage. J Clin Pharmacol 2012;52:114-6. [CrossRef]
  • 6. Minor K, Mohan A. Severe leptospirosis: treatment with intravenous corticosteroids and supportive care. Am J Emerg Med 2013;31:449.e1-2. [CrossRef]
Toplam 6 adet kaynakça vardır.

Ayrıntılar

Diğer ID JA53MM73UR
Bölüm Editoryal
Yazarlar

Berat Ebik Bu kişi benim

Zülkif Tanrıverdi Bu kişi benim

Şuayp Öygen Bu kişi benim

Yusuf Kayran Bu kişi benim

Yayımlanma Tarihi 1 Ocak 2016
Yayımlandığı Sayı Yıl 2016 Cilt: 33 Sayı: 1

Kaynak Göster

APA Ebik, B., Tanrıverdi, Z., Öygen, Ş., Kayran, Y. (2016). High Efficacy of Prednisolone in a Complicated Case of Weil Disease. Balkan Medical Journal, 33(1).
AMA Ebik B, Tanrıverdi Z, Öygen Ş, Kayran Y. High Efficacy of Prednisolone in a Complicated Case of Weil Disease. Balkan Medical Journal. Ocak 2016;33(1).
Chicago Ebik, Berat, Zülkif Tanrıverdi, Şuayp Öygen, ve Yusuf Kayran. “High Efficacy of Prednisolone in a Complicated Case of Weil Disease”. Balkan Medical Journal 33, sy. 1 (Ocak 2016).
EndNote Ebik B, Tanrıverdi Z, Öygen Ş, Kayran Y (01 Ocak 2016) High Efficacy of Prednisolone in a Complicated Case of Weil Disease. Balkan Medical Journal 33 1
IEEE B. Ebik, Z. Tanrıverdi, Ş. Öygen, ve Y. Kayran, “High Efficacy of Prednisolone in a Complicated Case of Weil Disease”, Balkan Medical Journal, c. 33, sy. 1, 2016.
ISNAD Ebik, Berat vd. “High Efficacy of Prednisolone in a Complicated Case of Weil Disease”. Balkan Medical Journal 33/1 (Ocak 2016).
JAMA Ebik B, Tanrıverdi Z, Öygen Ş, Kayran Y. High Efficacy of Prednisolone in a Complicated Case of Weil Disease. Balkan Medical Journal. 2016;33.
MLA Ebik, Berat vd. “High Efficacy of Prednisolone in a Complicated Case of Weil Disease”. Balkan Medical Journal, c. 33, sy. 1, 2016.
Vancouver Ebik B, Tanrıverdi Z, Öygen Ş, Kayran Y. High Efficacy of Prednisolone in a Complicated Case of Weil Disease. Balkan Medical Journal. 2016;33(1).